Farmsintez OAO (LIFE) Stock Price, Chart & News

Earn 10$ Cash for every Pro+ Friend you Refer!

LIFE

3.29

RUB0.175.27%

Overview

Profile

Statistics

Earnings

Financials

News

Chart

Day Range

3.06RUB

3.29RUB

52 Week Range

2.87RUB

5.96RUB

Market Cap

20.46MRUB

About

Public Joint-Stock Company Pharmsynthez, a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia, Europe, the United States, and CIS countries. The company offers officinal medicines, including Neovir, Segidrin, Glaumax, Vazostenon, Neostim, Fludarabel, Fenazide, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis. Public Joint-Stock Company Pharmsynthez was founded in 1996 and is based in St. Petersburg, Russia.

General Information

Type

Common Stock

Exchange

MCX

Currency Code

RUB

Currency Name

Russian Rouble

Country Name

Russia

Country ISO

ISIN

RU000A0JR514

CUSIP

Sector

Healthcare

Industry

Biotechnology

Fiscal Year End

December

IPO date

Updated At

Highlights

PE Ratio

11.49

PEG Ratio

Book Value

2.48

Dividend Share

Dividend Yield

Earnings Share

-2.3162

Wall Street Target Price

EPS Estimate Current Year

EPS Estimate Next Year

EPS Estimate Current Quarter

EPS Estimate Next Quarter

Most Recent Quarter

Profitability

Revenue TTM

451,315,008

Gross Profit TTM

159,921,000

EBITDA

-238,610,000

Profit Margin

-148.38%

Return On Assets TTM

-8.10%

Return On Equity TTM

-10262.60%

Revenue Per Share TTM

1.495

Qtly Revenue Growth YOY

56.00%

Diluted Eps TTM

-2.218

Qtly Earnings Growth YOY

0.00%

Valuation

Trailing PE

0.00

Forward PE

Price Sales TTM

3.0047

Price Book MRQ

3.4043

Enterprise Value Revenue

Enterprise Value EBITDA

-4

Peers analysis

What are you waiting for?Start making profit today

Tools

Plans

Markets

Resources

Compare

Profit mobile app

Discover the world of finance in your pocket

2024